Civic Intelligence

Frontiers in Bioscience Inc.

990 • Fiscal year 2016 • EIN 59-3432665

Jan 01, 2016 to Dec 31, 2016 • Filed on Jul 13, 2017

20 Sunset CoveNewport Coast, CA 92657

(949) 715-8286

Siviq Scores

Scores are not available for this record yet.

Balance Sheet

Assets

Up

$7,719,461

Up $2,224 (+0.0%) from 2015

Net Assets

Up

$7,579,662

Up $24,372 (+0.3%) from 2015

Liabilities

Down

$139,799

Down $22,148 (-14%) from 2015

Revenue And Expenses

Revenue

Down

$686,860

Down $272,606 (-28%) from 2015

Expenses

Up

$662,488

Up $93,882 (+17%) from 2015

Net Income

Down

$24,372

Down $366,488 (-94%) from 2015

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$10M$5.0M$0Assets 2011: $6,072,390Liabilities 2011: $145,555Net Assets 2011: $5,926,8352011Assets 2012: $6,593,702Liabilities 2012: $161,267Net Assets 2012: $6,432,4352012Assets 2013: $7,019,430Liabilities 2013: $158,293Net Assets 2013: $6,861,1372013Assets 2014: $7,380,585Liabilities 2014: $279,146Net Assets 2014: $7,101,4392014Assets 2015: $7,717,237Liabilities 2015: $161,947Net Assets 2015: $7,555,2902015Assets 2016: $7,719,461Liabilities 2016: $139,799Net Assets 2016: $7,579,6622016Assets 2017: $7,939,484Liabilities 2017: $38,338Net Assets 2017: $7,901,1462017Assets 2018: $8,152,585Liabilities 2018: $31,140Net Assets 2018: $8,121,4452018Assets 2019: $8,329,196Liabilities 2019: $28,843Net Assets 2019: $8,300,3532019Assets 2020: $9,154,107Liabilities 2020: $192,253Net Assets 2020: $8,961,8542020Assets 2021: $9,263,668Liabilities 2021: $187,520Net Assets 2021: $9,076,1482021Assets 2022: $9,068,473Liabilities 2022: $175,870Net Assets 2022: $8,892,6032022Assets 2023: $9,132,862Liabilities 2023: $252,072Net Assets 2023: $8,880,7902023Assets 2024: $9,147,259Liabilities 2024: $244,048Net Assets 2024: $8,903,2112024Assets 2025: $8,977,418Liabilities 2025: $246,462Net Assets 2025: $8,730,9562025

Highlighted filing

2016

Assets$7,719,461
Liabilities$139,799
Net Assets$7,579,662

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KExpenses 2011: $303,3232011Expenses 2012: $566,8742012Revenue 2013: $1,020,368Expenses 2013: $591,666Net Income 2013: $428,7022013Revenue 2014: $929,379Expenses 2014: $583,280Net Income 2014: $346,0992014Revenue 2015: $959,466Expenses 2015: $568,606Net Income 2015: $390,8602015Revenue 2016: $686,860Expenses 2016: $662,488Net Income 2016: $24,3722016Revenue 2017: $884,845Expenses 2017: $563,361Net Income 2017: $321,4842017Revenue 2018: $687,687Expenses 2018: $467,385Net Income 2018: $220,3022018Revenue 2019: $665,550Expenses 2019: $464,587Net Income 2019: $200,9632019Revenue 2020: $1,172,136Expenses 2020: $303,230Net Income 2020: $868,9062020Revenue 2021: $287,321Expenses 2021: $239,359Net Income 2021: $47,9622021Revenue 2022: $130,196Expenses 2022: $272,103Net Income 2022: -$141,9072022Revenue 2023: $252,831Expenses 2023: $264,644Net Income 2023: -$11,8132023Revenue 2024: $159,183Expenses 2024: $334,551Net Income 2024: -$175,3682024Revenue 2025: $179,746Expenses 2025: $394,681Net Income 2025: -$214,9352025

Highlighted filing

2016

Revenue$686,860
Expenses$662,488
Net Income$24,372
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Signed
Jul 13, 2017
Return Version
2016v3.0
Gross Receipts
$776,932
Mission and Program Overview

Mission

Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.

Frontiers in bioscience is an organization dedicated to fostering science, research and teaching. Fbs has been involved in these activities since jan 1 1996. Fbs has published over 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and recurrence as well as understanding the cause of disturbed metabolism (warburg's effect) of cancer cells. Such an insight is significant since it provides us with new avenues for treatment of cancer or cancer cure. The treatment of cancer based, on our hypothesis, is founded on new non-chemotherapeutic and non-radiotherpay approaches. We also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or dece

Balance Sheet Detail
LineBeginningEndChange
Assets
Land, Buildings, and Equipment, Net$4,678,218$4,588,512▼ $89,706
Cash and Non-Interest-Bearing Accounts$3,034,342$3,125,497▲ $91,155
Loans From Officers Directors$159,953$120,237▼ $39,716
Investments in Publicly Traded Securities$4,660$4,660→ $0
Other Notes and Loans Receivable, Net$17$792▲ $775
Total Assets$7,717,237$7,719,461▲ $2,224
Liabilities
Other Liabilities-$16,290-
Accounts Payable and Accrued Expenses$1,994$3,272▲ $1,278
Total Liabilities$161,947$139,799▼ $22,148
Net Assets / Fund Balance
Unrestricted Net Assets$7,555,290$7,579,662▲ $24,372
Total Net Assets Fund Balance$7,555,290$7,579,662▲ $24,372
Total Liabilities and Net Assets / Fund Balance$7,717,237$7,719,461▲ $2,224

Asset Categories

AssetBook ValueDepreciationBasis
Land$2,854,413-$1,555,474
Buildings$1,658,752$320,193$1,227,758
Equipment$57,000$287,218$344,218
Other Land Buildings$18,347$51,708$70,055
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Siamak Tabibzadeh MdPresident/ceFT$88,000$2,400$90,400

Board Members and Trustees

NameTitle
John TabacekDirector / T
Richard CushmanDirector/sec
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$656,803
Investment Income
$10,651
Other Revenue
$19,406
Change in Net Assets
$24,372
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$338,193
Salaries, Compensation, and Employee Benefits$324,295
Total Fundraising Expense$12,520
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$199,099--$199,099
Current Officers, Directors, Trustees, and Key Employees$70,400$8,800$8,800$88,000
Fees for Services Legal-$85,632-$85,632
Depreciation Depletion$62,390--$62,390
Payroll Taxes$19,440$2,430$2,430$24,300
Fees for Services Accounting-$19,769-$19,769
Fees for Services Other$19,313--$19,313
All Other Expenses$16,369--$16,369
Occupancy$13,420--$13,420
Other Employee Benefits$10,316$1,290$1,290$12,896
Other Expenses$11,423--$11,423
Insurance$4,421--$4,421
Office Expenses$4,204--$4,204
Information Technology$2,118--$2,118
Travel$582--$582
Interest-$139-$139
Total Functional Expenses$531,908$118,060$12,520$662,488
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
Siamak TabibzadehCEOLead InvestigatorNo$80,000
Siamak TabibzadehCEOLead InvestigatorNo$30,000

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$159,953$120,237▼ $39,716
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Tenant Deposits in Trust$16,290
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with family members
No
Business relationship with organization members
Yes
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

The form 990 is reviewed with the cpa consultant as to accuracy and completeness.

Form 990, Page 6, Part VI, Line 12C

Conflict of interest policy - the board of directors reviews self-dealing transactions regularly.

Form 990, Page 6, Part VI, Line 19

AVAIABLE UPON REQUEST.

Filing and Contact Details

Filer

Filer Name
Frontiers in Bioscience
EIN
59-3432665
Phone
9497158286
Address
20 SUNSET COVE, NEWPORT COAST, CA 92657

Signing Officer

Name
Siamak Tabibzadeh Md
Title
President/CEO
Phone
9497158286
Signed
2017-07-13
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Siamak Tabibzadeh Md
Formed
1995
Legal Domicile
Fl
Voting Board Members
3
Independent Board Members
2
Employees
6

Preparer

Firm
Invisible Accounting Solutions Aac
Address
23072 LAKE CENTER DRIVE SUITE 210, LAKE FOREST, CA 92630-2899
Preparer
Ardavan Keyhan CPA
Phone
9496541400
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

Frontiers in bioscience is an organization dedicated to fostering science, research and teaching. Fbs has been involved in these activities since jan 1 1996. Fbs has published over 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and recurrence as well as understanding the cause of disturbed metabolism (warburg's effect) of cancer cells. Such an insight is significant since it provides us with new avenues for treatment of cancer or cancer cure. The treatment of cancer based, on our hypothesis, is founded on new non-chemotherapeutic and non-radiotherpay approaches. We also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or decelarated in animal modes before they can be adopted in humans. We will use stem cells as well signaling molecules to achieve such therapeutic end. We hope that our findings will help humanity in a grand scale.

Form 990, Page 2, Part III, Line 4A

Also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or decelarated in animal modes before they can be adopted in humans. We will use stem cells as well signaling molecules to achieve such therapeutic end. We hope that our findings will help humanity in a grand scale.

Form 990, Part XI, Line 9

Officer loan interest accrued-current 0 officer loan interest accrued-prior 0 officer loan interest accrual 0

Raw XML Appendix387 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt01994
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt03272
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECE
IRS990/AllOtherExpensesGrp/ProgramServicesAmt016369
IRS990/AllOtherExpensesGrp/TotalAmt016369
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BooksInCareOfDetail/PersonNm0SIAMAK TABIBZADEH MD
IRS990/BooksInCareOfDetail/PhoneNum09497158286
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEWPORT COAST
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd092657
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOfficerEntInd0false
IRS990/BusinessRlnWithOrgMemInd0true
IRS990/CashNonInterestBearingGrp/BOYAmt03034342
IRS990/CashNonInterestBearingGrp/EOYAmt03125497
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt08800
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt08800
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt070400
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt088000
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt010651
IRS990/CYOtherExpensesAmt0338193
IRS990/CYOtherRevenueAmt019406
IRS990/CYProgramServiceRevenueAmt0656803
IRS990/CYRevenuesLessExpensesAmt024372
IRS990/CYSalariesCompEmpBnftPaidAmt0324295
IRS990/CYTotalExpensesAmt0662488
IRS990/CYTotalFundraisingExpenseAmt012520
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0686860
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ProgramServicesAmt062390
IRS990/DepreciationDepletionGrp/TotalAmt062390
IRS990/Desc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt06
IRS990/EmploymentTaxReturnsFiledInd0false
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0531908
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt019769
IRS990/FeesForServicesAccountingGrp/TotalAmt019769
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt085632
IRS990/FeesForServicesLegalGrp/TotalAmt085632
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt019313
IRS990/FeesForServicesOtherGrp/TotalAmt019313
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt15.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt22.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt02400
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0SIAMAK TABIBZADEH MD
IRS990/Form990PartVIISectionAGrp/PersonNm1JOHN TABACEK
IRS990/Form990PartVIISectionAGrp/PersonNm2RICHARD CUSHMAN
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt088000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT/CE
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR / T
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR/SEC
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr01995
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt0776932
IRS990/GrossRentsGrp/RealAmt0109478
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt02
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ProgramServicesAmt02118
IRS990/InformationTechnologyGrp/TotalAmt02118
IRS990/InsuranceGrp/ProgramServicesAmt04421
IRS990/InsuranceGrp/TotalAmt04421
IRS990/InterestGrp/ManagementAndGeneralAmt0139
IRS990/InterestGrp/TotalAmt0139
IRS990/InvestmentIncomeGrp/ExclusionAmt010651
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt010651
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsPubTradedSecGrp/BOYAmt04660
IRS990/InvestmentsPubTradedSecGrp/EOYAmt04660
IRS990/IRPDocumentCnt02
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0659119
IRS990/LandBldgEquipBasisNetGrp/BOYAmt04678218
IRS990/LandBldgEquipBasisNetGrp/EOYAmt04588512
IRS990/LandBldgEquipCostOrOtherBssAmt05247631
IRS990/LegalDomicileStateCd0FL
IRS990/LessRentalExpensesGrp/RealAmt090072
IRS990/LoanOutstandingInd0true
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt0159953
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt0120237
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECE
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt07555290
IRS990/NetAssetsOrFundBalancesEOYAmt07579662
IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt019406
IRS990/NetRentalIncomeOrLossGrp/UnrelatedBusinessRevenueAmt019406
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/ProgramServicesAmt013420
IRS990/OccupancyGrp/TotalAmt013420
IRS990/OfficeExpensesGrp/ProgramServicesAmt04204
IRS990/OfficeExpensesGrp/TotalAmt04204
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt01290
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt01290
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt010316
IRS990/OtherEmployeeBenefitsGrp/TotalAmt012896
IRS990/OtherExpensesGrp/Desc0LABORATORY SUPPLIES/FEES
IRS990/OtherExpensesGrp/Desc1PROPERTY TAXES
IRS990/OtherExpensesGrp/Desc2ASSOCIATION DUES
IRS990/OtherExpensesGrp/Desc3MERCHANT SERVICE FEES
IRS990/OtherExpensesGrp/ProgramServicesAmt044102
IRS990/OtherExpensesGrp/ProgramServicesAmt140144
IRS990/OtherExpensesGrp/ProgramServicesAmt214167
IRS990/OtherExpensesGrp/ProgramServicesAmt311423
IRS990/OtherExpensesGrp/TotalAmt044102
IRS990/OtherExpensesGrp/TotalAmt140144
IRS990/OtherExpensesGrp/TotalAmt214167
IRS990/OtherExpensesGrp/TotalAmt311423
IRS990/OtherLiabilitiesGrp/EOYAmt016290
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0199099
IRS990/OtherSalariesAndWagesGrp/TotalAmt0199099
IRS990/OthNotesLoansReceivableNetGrp/BOYAmt017
IRS990/OthNotesLoansReceivableNetGrp/EOYAmt0792
IRS990/PartialLiquidationInd0false
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/FundraisingAmt02430
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt02430
IRS990/PayrollTaxesGrp/ProgramServicesAmt019440
IRS990/PayrollTaxesGrp/TotalAmt024300
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0SIAMAK TABIBZADEH MD
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/Desc0PROGRAM SERVICE REVENUE
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0656803
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0656803
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt057283
IRS990/PYOtherExpensesAmt0291069
IRS990/PYProgramServiceRevenueAmt0902183
IRS990/PYRevenuesLessExpensesAmt0390860
IRS990/PYSalariesCompEmpBnftPaidAmt0277537
IRS990/PYTotalExpensesAmt0568606
IRS990/PYTotalRevenueAmt0959466
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReconcilationRevenueExpnssAmt024372
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/RentalIncomeOrLossGrp/RealAmt019406
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt0656803
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt010651
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt0883
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt05914
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt07546
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt012028
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt037022
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt0656803
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0902183
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt0923465
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt01012822
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt01060446
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt04555719
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt010651
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt0883
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt05914
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt07546
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt012028
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt037022
IRS990ScheduleA/InvestmentIncomeCYPct00.01000
IRS990ScheduleA/InvestmentIncomePYPct00.01000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99190
IRS990ScheduleA/PublicSupportPY509Pct00.99210
IRS990ScheduleA/PublicSupportTotal509Amt04555719
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0656803
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0902183
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0923465
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt01012822
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt01060446
IRS990ScheduleA/Total509Grp/TotalAmt04555719
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0667454
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0903066
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0929379
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt01020368
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt01072474
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt04592741
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/BuildingsGrp/BookValueAmt01658752
IRS990ScheduleD/BuildingsGrp/DepreciationAmt0320193
IRS990ScheduleD/BuildingsGrp/InvestmentCostOrOtherBasisAmt0751187
IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt01227758
IRS990ScheduleD/EquipmentGrp/BookValueAmt057000
IRS990ScheduleD/EquipmentGrp/DepreciationAmt0287218
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0344218
IRS990ScheduleD/LandGrp/BookValueAmt02854413
IRS990ScheduleD/LandGrp/InvestmentCostOrOtherBasisAmt01298939
IRS990ScheduleD/LandGrp/OtherCostOrOtherBasisAmt01555474
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt018347
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt051708
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt070055
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt016290
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0TENANT DEPOSITS IN TRUST
IRS990ScheduleD/TotalBookValueLandBuildingsAmt04588512
IRS990ScheduleD/TotalLiabilityAmt016290
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/NameOfInterested/PersonNm0SIAMAK TABIBZADEH
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/NameOfInterested/PersonNm1SIAMAK TABIBZADEH
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/RelationshipDescriptionTxt0CEO
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/RelationshipDescriptionTxt1CEO
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/SharingOfRevenuesInd0false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/SharingOfRevenuesInd1false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionAmt080000
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionAmt130000
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionDesc0LEAD INVESTIGATOR
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionDesc1LEAD INVESTIGATOR
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt0120237
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt0154000
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm0SIAMAK TABIBZADEH PROMISSORY NOTE
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0CEO
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0true
IRS990ScheduleL/SupplementalInformationDetail/ExplanationTxt0SALARY DEFERRED SALARIES
IRS990ScheduleL/SupplementalInformationDetail/FormAndLineReferenceDesc0SCHEDULE L, PART V
IRS990ScheduleL/TotalBalanceDueAmt0120237
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE FORM 990 IS REVIEWED WITH THE CPA CONSULTANT AS TO ACCURACY AND COMPLETENESS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3CONFLICT OF INTEREST POLICY - THE BOARD OF DIRECTORS REVIEWS SELF-DEALING TRANSACTIONS REGULARLY.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4AVAIABLE UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5OFFICER LOAN INTEREST ACCRUED-CURRENT 0 OFFICER LOAN INTEREST ACCRUED-PRIOR 0 OFFICER LOAN INTEREST ACCRUAL 0
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 2, PART III, LINE 4A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART XI, LINE 9
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToProxyTaxInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TempOrPermanentEndowmentsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt07717237
IRS990/TotalAssetsEOYAmt07719461
IRS990/TotalAssetsGrp/BOYAmt07717237
IRS990/TotalAssetsGrp/EOYAmt07719461
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt06
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt012520
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt0118060
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0531908
IRS990/TotalFunctionalExpensesGrp/TotalAmt0662488
IRS990/TotalGrossUBIAmt019406
IRS990/TotalLiabilitiesBOYAmt0161947
IRS990/TotalLiabilitiesEOYAmt0139799
IRS990/TotalLiabilitiesGrp/BOYAmt0161947
IRS990/TotalLiabilitiesGrp/EOYAmt0139799
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt07555290
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt07579662
IRS990/TotalOtherCompensationAmt02400
IRS990/TotalProgramServiceExpensesAmt0531908
IRS990/TotalProgramServiceRevenueAmt0656803
IRS990/TotalReportableCompFromOrgAmt088000
IRS990/TotalRevenueGrp/ExclusionAmt010651
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0656803
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0686860
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt019406
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt07717237
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt07719461
IRS990/TravelGrp/ProgramServicesAmt0582
IRS990/TravelGrp/TotalAmt0582
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UnrestrictedNetAssetsGrp/BOYAmt07555290
IRS990/UnrestrictedNetAssetsGrp/EOYAmt07579662
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/USAddress/CityNm0NEWPORT COAST
IRS990/USAddress/StateAbbreviationCd0CA
IRS990/USAddress/ZIPCd092657
IRS990/VotingMembersGoverningBodyCnt03
IRS990/VotingMembersIndependentCnt02
IRS990/WebsiteAddressTxt0WWW.BIOSCIENCE.ORG
IRS990/WhistleblowerPolicyInd0true
ReturnHeader/BuildTS02017-02-10 21:41:12Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0SIAMAK TABIBZADEH MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT/CEO
ReturnHeader/BusinessOfficerGrp/PhoneNum09497158286
ReturnHeader/BusinessOfficerGrp/SignatureDt02017-07-13
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0FRONTIERS IN BIOSCIENCE
ReturnHeader/Filer/BusinessNameControlTxt0FRON
ReturnHeader/Filer/EIN0593432665
ReturnHeader/Filer/PhoneNum09497158286
ReturnHeader/Filer/USAddress/AddressLine1Txt020 SUNSET COVE
ReturnHeader/Filer/USAddress/CityNm0NEWPORT COAST
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092657
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId0C9EA127B1123C2B9B9F7603DADE3E0DDF46E87D1
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId09B378BFF7B0BDFFE79585F0726D6BACE7AD7E6C0
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0471076451
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0INVISIBLE ACCOUNTING SOLUTIONS AAC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt023072 LAKE CENTER DRIVE SUITE 210
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0LAKE FOREST
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0926302899
ReturnHeader/PreparerPersonGrp/PhoneNum09496541400
ReturnHeader/PreparerPersonGrp/PreparationDt02017-10-19
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0ARDAVAN KEYHAN CPA
ReturnHeader/ReturnTs02017-10-23T14:57:47-07:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02016-01-01
ReturnHeader/TaxPeriodEndDt02016-12-31
ReturnHeader/TaxYr02016

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$8.98$0.25$8.73$0.18$0.39$0.21
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.24$8.90$0.16$0.33$0.18
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.13$0.25$8.88$0.25$0.26$0.01
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.07$0.18$8.89$0.13$0.27$0.14
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.26$0.19$9.08$0.29$0.24$0.05
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.19$8.96$1.17$0.30$0.87
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.33$0.03$8.30$0.67$0.46$0.20
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.15$0.03$8.12$0.69$0.47$0.22
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.94$0.04$7.90$0.88$0.56$0.32
2016Detailed filing. Detailed filing data is available for this year.$7.72$0.14$7.58$0.69$0.66$0.02
2015Detailed filing. Detailed filing data is available for this year.$7.72$0.16$7.56$0.96$0.57$0.39
2014Detailed filing. Detailed filing data is available for this year.$7.38$0.28$7.10$0.93$0.58$0.35
2013XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.02$0.16$6.86$1.02$0.59$0.43
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.59$0.16$6.43$0.57
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.07$0.15$5.93$0.30